Austedo Xr Tablet, Film Coated, Extended Release
Pricing Report NDC 68546-479-56

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Austedo Xr (NDC 68546-479-56) is $251.07040 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 17, 2026.

As a a human prescription drug provided by Teva Neuroscience, Inc., this medication is distributed in a 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$251.07040
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jun 17, 2026
Billable Units
30 EA
Estimated Package Price
$7,532.11
Data Status
As of Jul 08, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
68546-479-56
Description
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Sep 2025, the NADAC wholesale price for (NDC ) has moved within a range of $238.11404 to $251.51577 per EA. Over this 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$238.1140 - $251.5158
Market Volatility
5.63% Variance
Latest Trend
0.09%
Date Unit Price Unit Source Method Rate
Jun 17, 2026 $251.07040 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $251.29371 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 01, 2026 $251.51577 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jan 01, 2026 $251.51577 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jan 01, 2026 $251.51577 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Dec 17, 2025 $238.40357 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $238.83128 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $238.42206 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 17, 2025 $238.11404 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026